Field research in Tropical Medicine, and Mother and Child Health. Malaria, nutrition, neglected disease, HIV, TB, paediatrics, Epilepsy, access to treatment, treatments for children.
http://www.malariajournal.com/content/pdf/1475-2875-7-242.pdf
and
http://www.malariajournal.com/content/7/1/242
Published in
Malaria Journal 2008, 7:242 doi:10.1186/1475-2875-7-242
Abstract
Background
Hypoglycaemia is a poor prognostic indicator in severe malaria. Intravenous infusions
are rarely feasible in rural areas. The efficacy of sublingual sugar (SLS) was assessed
in a pilot randomized controlled trial among hypoglycaemic children with severe
malaria in Mali.
Methods
Of 151 patients with presumed severe malaria, 23 children with blood glucose
concentrations <60 mg/dl (<3.3mmol/l) were assigned randomly to receive either
intravenous 10% glucose (IVG; n=9) or sublingual sugar (SLS; n=14). In SLS, a
teaspoon of sugar, moistened with a few drops of water, was gently placed under the
tongue every 20 minutes. The child was put in the recovery position. Blood glucose
concentration (BGC) was measured every 5-10 minutes for the first hour. All children
were treated for malaria with intramuscular artemether. The primary outcome
measure was treatment response, defined as reaching a BGC of >= 3.3mmol/l
(60mg/dl) within 40 minutes after admission. Secondary outcome measures were
early treatment response at 20 minutes, relapse (early and late), maximal BGC gain
(CGmax), and treatment delay.
Results
There was no significant difference between the groups in the primary outcome
measure. Treatment response occurred in 71% and 67% for SLS and IVG,
respectively. Among the responders, relapses occurred in 30% on SLS at 40 minutes
and in 17% on IVG at 20 minutes. There was one fatality in each group. Treatment
failures in the SLS group were related to children with clenched teeth or swallowing
the sugar, whereas in the IVG group, they were due to unavoidable delays in
beginning an infusion (median time 17.5 min (range 3-40).
Among SLS, the BGC increase was rapid among the nine patients who really kept the
sugar sublingually. All but one increased their BGC by 10 minutes with a mean gain
of 44 mg/dl (95%CI: 20.5-63.4).
Conclusions
Sublingual sugar appears to be a child-friendly, well-tolerated and effective promising
method of raising blood glucose in severely ill children. More frequent repeated doses
are needed to prevent relapse. Children should be monitored for early swallowing
which leads to delayed absorption, and in this case another dose of sugar should be
given. Sublingual sugar could be proposed as an immediate “first aid” measure while
awaiting intravenous glucose. In many cases it may avert the need for intravenous
glucose.